Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...

Derbyshire council’s Cabinet has agreed to introduce a raft of cutbacks and money-saving changes in four key areas involving ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Relationships between a client and their financial adviser can sometimes get awkward. Money stirs our emotions, potentially ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.

BXCL501 is under investigation by BioXcel Therapeutics for the acute treatment of agitation associated with Alzheimer’s dementia and for the acute treatment of agitation associated with bipolar I or ...

She's spent many hours doing research and speaking with other caregivers to find her way to resources designed to help ...

How to manage hypertension and dementia risk Researchers do not fully understand the direct causes of hypertension, Daugherty ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...